Skip to content

Translation and Validation of a Disease-specific Questionnaire for Hirschsprung's Disease in Danish Patients

Translation and Validation of the Hirschsprung and Anorectal Malformation Quality of Life (HAQL) Questionnaire in a Danish Hirschsprung Population

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04730128
Enrollment
173
Registered
2021-01-29
Start date
2020-07-01
Completion date
2021-05-15
Last updated
2022-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hirschsprung Disease

Keywords

Hirschsprung Disease, Quality of Life, Translation and validation

Brief summary

The Hirschsprung and anorectal malformation quality of life (HAQL) questionnaire is a disease-specific quality of life questionnaire with 5 different elements (3 questionnaires for patients (categories: age 8-11, 12-16, and \>17 years) and two questionnaires for parents of patients (categories: patients aged 8-11 and 12-16 years). In the first part of this study, the questionnaires will be translated via forward-backward-translation, culturally adapted and evaluated for content validity. In the second part of the study, the questionnaires will be validated in a cohort of all eligible Hirschsprung patients from Odense University Hospital from 1985-2014.

Interventions

None listed

Sponsors

Odense University Hospital
CollaboratorOTHER
University of Southern Denmark
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
8 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed with Hirschsprung's Disease between the years 1985-2014 * Age \> 7 years * Good Danish comprehension * Signed informed consent

Exclusion criteria

* Inability to follow the procedures of the study, e.g. due to language problems, severe psychological disorders, dementia, etc.

Design outcomes

Primary

MeasureTime frame
Internal Consistency (IC) assessed by Cronbach's AlphaDay 1

Secondary

MeasureTime frame
Test-retest reliability assessed by intraclass-correlations coefficient4 weeks

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026